查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1427987

2024 年治疗诊断学全球市场报告

Radiotheranostics Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

治疗诊断学市场规模预计在未来几年将快速成长。预计到 2028 年将以 13.7% 的复合年增长率 (CAGR) 增长至 146.1 亿美元。预测期内的预期增长可归因于标靶治疗的进步、肿瘤学研究的扩展、慢性病的增加以及治疗应用的增长。预测期内预期的显着趋势包括治疗性放射性药物的开发、肿瘤学以外的应用扩展、个人化放射性药物的客製化、奈米技术与治疗诊断学的整合、法规结构和标准化。

癌症发生率的预期增加预计将推动未来几年治疗诊断学市场的成长。癌症的特征是不受控制的细胞生长并扩散到全身，这种疾病需要有针对性的个人化方法来进行有效的诊断和治疗。治疗诊断学药物透过结合诊断和治疗放射性核素探针在癌症治疗中发挥重要作用。这种方法能够根据患者的独特情况，选择性地、有针对性地检测和治疗特定细胞，尤其是癌细胞。英国癌症研究中心报告称，2020 年新增癌症病例约为 1800 万例，全球预测估计到 2040 年每年新增癌症病例将达到 2800 万例。与 2020 年相比增加了 54.9%。癌症盛行率的上升是治疗诊断学市场扩张的关键驱动力。

个人化医疗的日益普及必将促进治疗诊断学市场的成长。个人化医疗是一种创新的医疗方法，可根据患者的个别特征制定治疗方案，并透过治疗诊断学加以促进。这种方法利用特定的放射性药物，能够识别个体化的分子标靶，从而能够根据患者的独特特征进行准确的诊断和个体化的治疗性介入。据个人化医疗联盟称，食品药物管理局药物评估与研究中心（CDER）在2022年核准了37个新分子实体（NME），其中约34%被归类为个人化医疗。个人化医疗的日益采用是治疗诊断学市场成长的关键驱动力。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球治疗诊断学市场的驱动与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023年全球治疗诊断学市场规模表现与成长
  • 全球治疗诊断学市场规模与成长预测，2023-2028、2033

第六章市场区隔

  • 全球治疗诊断学市场，依放射性同位素细分，实际与预测，2018-2023、2023-2028、2033
  • Technetium99
  • 镓68
  • 碘131
  • 碘123
  • 氟脱氧葡萄糖-18F
  • 钇90
  • 镏(Lu) 177
  • 铜 (Cu)67
  • 铜 (Cu)64
  • 其他的
  • 全球治疗诊断学市场，依方法、实际及预测细分，2018-2023、2023-2028、2033
  • 标靶治疗
  • 针对性诊断
  • 全球治疗诊断学市场，按应用、实际和预测细分，2018-2023、2023-2028、2033
  • 瘤
  • 非肿瘤
  • 全球治疗诊断学市场，按最终用户细分，实际和预测，2018-2023、2023-2028、2033
  • 医院和诊所
  • 製药和生物技术公司
  • 其他的

第 7 章 区域与国家分析

  • 全球治疗诊断学市场，按地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球治疗诊断学市场，依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 治疗诊断学市场的竞争形势
  • 治疗诊断学市场公司概况
    • Lantheus Holdings Inc.
    • Cardinal Health Inc.
    • GE Healthcare Inc.
    • Bayer AG
    • Novartis AG

第31章 其他大型创新公司

  • Siemens Healthineers
  • Boston Scientific Corporation
  • Terumo Corporation
  • Orano Med
  • Curium SAS
  • IBA Molecular
  • The Eckert &Ziegler Group
  • Advanced Accelerator Applications（AAA）
  • Telix Pharmaceuticals Limited.
  • Abdera Therapeutics
  • Blue Earth Diagnostics
  • Sirtex Medical Limited
  • Y-mAbs Therapeutics Inc.
  • ITM Radiopharma
  • NorthStar Medical Radioisotopes LLC

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与潜力分析

第36章附录

简介目录
Product Code: r13831

Radiotheranostics refers to a medical approach that combines diagnoses and treatments using imaging methods with radioactive substances to precisely identify specific targets within the body. This method is employed for delivering targeted radiation therapy to defined locations, enabling precise and tailored cancer treatment while minimizing damage to healthy tissues. This approach enhances treatment outcomes and improves patient care.

The primary radiotheranostics radioisotopes include technetium-99, gallium-68, iodine-131, iodine-123, fludeoxyglucose-18F, yttrium-90, lutetium (Lu) 177, copper (Cu) 67, copper (Cu) 64, and others. Technetium (Tc) is a silver-gray radioactive metal that occurs naturally at extremely low levels in the earth's crust but is predominantly man-made. It is used for skeletal and heart muscle scans and imaging of various organs such as the brain, thyroid, lungs, liver, spleen, kidneys, gall bladder, bone marrow, salivary and lacrimal glands, as well as in some specialized medical research. The different approaches include targeted therapeutic and targeted diagnostic applications in both oncology and non-oncology. The end users of this technology include hospitals and clinics, pharmaceutical and biotechnology companies, and others.

The radio theranostics market research report is one of a series of new reports from The Business Research Company that provides radio theranostics market statistics, including radio theranostics industry global market size, regional shares, competitors with a radio theranostics market share, detailed radio theranostics market segments, market trends, and opportunities, and any further data you may need to thrive in the radio theranostics industry. This radio theranostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The radiotheranostics market size has grown rapidly in recent years. It will grow from $7.57 billion in 2023 to $8.74 billion in 2024 at a compound annual growth rate (CAGR) of 15.3%. The increase observed in the historical period can be attributed to advancements in nuclear medicine, a rise in cancer cases, the development of personalized medicine, progress in radiopharmaceuticals, and the establishment of regulatory approvals and standards.

The radiotheranostics market size is expected to see rapid growth in the next few years. It will grow to $14.61 billion in 2028 at a compound annual growth rate (CAGR) of 13.7%. The anticipated growth in the forecast period can be attributed to advancements in targeted cancer therapies, the expansion of oncology research, an increase in chronic diseases, and growth in theranostic applications. Prominent trends expected during the forecast period include the development of theranostic radiopharmaceuticals, extending applications beyond oncology, the customization of personalized radiopharmaceuticals, the integration of nanotechnology in radiotheranostics, and shifts in regulatory frameworks and standardization.

The projected increase in cancer prevalence is expected to drive the growth of the radiotheranostics market in the coming years. Cancer, characterized by uncontrolled cell growth and spread within the body, is a condition that necessitates targeted and personalized approaches for effective diagnosis and treatment. Radiotheranostics medications play a crucial role in cancer treatment by utilizing paired diagnostic and therapeutic radionuclide probes. This approach enables selective and targeted detection and treatment of specific cells, particularly cancer cells, tailored to the patient's unique condition. Cancer Research UK reported approximately 18 million new cancer cases in 2020, and global projections estimate 28 million new cases annually by 2040, reflecting a 54.9% increase from 2020. The rising prevalence of cancer serves as a significant driver for the expansion of the radiotheranostics market.

The increasing adoption of personalized medicine is poised to contribute to the growth of the radiotheranostics market. Personalized medicine, an innovative healthcare approach tailoring medical treatments to individual patient characteristics, is facilitated by radiotheranostics. This approach, utilizing specific radiopharmaceuticals, enables the identification of individualized molecular targets, allowing for precise diagnosis and tailored therapeutic interventions based on the patient's unique characteristics. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% classified as personalized medicines, according to the Personalized Medicine Coalition. The increasing adoption of personalized medicine is a key driver for the growth of the radiotheranostics market.

An emerging trend in the radiotheranostics market is the focus on product innovations. Major companies are directing their efforts towards creating innovative products to solidify their market positions. For instance, Advanced Cyclotron Systems Inc., a Canada-based company specializing in cyclotrons for medical isotope production, introduced TR-ALPHA in May 2023. This innovation is designed for the production of alpha-emitting radioisotopes used in cancer treatment. TR-ALPHA addresses market demands for a low-cost cyclotron capable of producing substantial amounts of Astatine-211, a promising alpha-emitting radioisotope. This product is smaller, more cost-effective, and easier to operate compared to previous cyclotron models, making it an ideal solution for efficiently producing therapeutic alpha-emitting radioisotopes.

Major companies in the radiotheranostics market are forming strategic partnerships to develop new products and strengthen their market positions. Collaborations and partnerships in this market facilitate the pooling of resources, expertise, and research efforts, accelerating the development, commercialization, and widespread adoption of advanced diagnostic and therapeutic solutions. In April 2022, Ion Beam Applications partnered with SCK CEN to advance the production of the radioisotope Actinium-225, a crucial element in cancer treatment. This collaboration aims to establish a state-of-the-art production facility in Mol, Belgium, combining expertise in particle accelerators and the provision of rare raw materials. Such collaborations are crucial for making radiotheranostic solutions commercially viable for treating various cancers with enhanced precision.

In June 2023, Ariceum Therapeutics GmbH, a Germany-based radiopharmaceutical company, acquired Theragnostics Ltd. for $41.5 million. This strategic acquisition is intended to broaden Ariceum's portfolio of therapeutic and diagnostic assets in late preclinical and early clinical development and expand its operations in the US. Theragnostics Ltd., a US-based radiopharmaceutical company, specializes in offering radio-theranostic solutions.

Major companies operating in the radiotheranostics market report are Lantheus Holdings Inc., Cardinal Health Inc., GE Healthcare Inc., Bayer AG, Novartis AG, Siemens Healthineers, Boston Scientific Corporation, Terumo Corporation, Orano Med, Curium SAS, IBA Molecular, The Eckert & Ziegler Group, Advanced Accelerator Applications (AAA), Telix Pharmaceuticals Limited., Abdera Therapeutics, Blue Earth Diagnostics, Sirtex Medical Limited, Y-mAbs Therapeutics Inc., ITM Radiopharma, NorthStar Medical Radioisotopes LLC, Trasis S.A., Molecular Targeting Technologies Inc., RadioMedix Inc., Clarity Pharmaceuticals, Actinium Pharmaceuticals Inc., Navidea Biopharmaceuticals Inc.

North America was the largest region in the radiotheranostics market in 2023. The regions covered in the radiotheranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the radiotheranostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The radiotheranostics market consists of sales of iodine-125, radium-223 (223Ra), astatin-211 (211At), actinium-225 (225Ac), lead-212 (212Pb), bismuth-212 (212Bi), thorium-227, strontium-89 (89Sr), rhenium-188 (188Re), and samarium-153 (153Sm). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radiotheranostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radiotheranostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for radiotheranostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The radiotheranostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Radioisotope: Technetium-99; Gallium-68; Iodine-131; Iodine-123; Fludeoxyglucose-18F; Yttrium-90; Lutetium (Lu) 177; Copper (Cu) 67; Copper (Cu) 64; Other Radioisotopes
  • 2) By Approach: Targeted Therapeutic; Targeted Diagnostic
  • 3) By Application: Oncology; Non-Oncology
  • 4) By End-Users: Hospitals and Clinics; Pharmaceutical and Biotechnology Companies; Other End-Users
  • Companies Mentioned: Lantheus Holdings Inc.; Cardinal Health Inc.; GE Healthcare Inc.; Bayer AG; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Radiotheranostics Market Characteristics

3. Radiotheranostics Market Trends And Strategies

4. Radiotheranostics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Radiotheranostics Market Size and Growth

  • 5.1. Global Radiotheranostics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Radiotheranostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Radiotheranostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Radiotheranostics Market Segmentation

  • 6.1. Global Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Technetium-99
  • Gallium-68
  • Iodine-131
  • Iodine-123
  • Fludeoxyglucose-18F
  • Yttrium-90
  • Lutetium (Lu) 177
  • Copper (Cu) 67
  • Copper (Cu) 64
  • Other Radioisotopes
  • 6.2. Global Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Targeted Therapeutic
  • Targeted Diagnostic
  • 6.3. Global Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Non-Oncology
  • 6.4. Global Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Other End-Users

7. Radiotheranostics Market Regional And Country Analysis

  • 7.1. Global Radiotheranostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Radiotheranostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Radiotheranostics Market

  • 8.1. Asia-Pacific Radiotheranostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Radiotheranostics Market

  • 9.1. China Radiotheranostics Market Overview
  • 9.2. China Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Radiotheranostics Market

  • 10.1. India Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Radiotheranostics Market

  • 11.1. Japan Radiotheranostics Market Overview
  • 11.2. Japan Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Radiotheranostics Market

  • 12.1. Australia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Radiotheranostics Market

  • 13.1. Indonesia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Radiotheranostics Market

  • 14.1. South Korea Radiotheranostics Market Overview
  • 14.2. South Korea Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Radiotheranostics Market

  • 15.1. Western Europe Radiotheranostics Market Overview
  • 15.2. Western Europe Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Radiotheranostics Market

  • 16.1. UK Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Radiotheranostics Market

  • 17.1. Germany Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Radiotheranostics Market

  • 18.1. France Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Radiotheranostics Market

  • 19.1. Italy Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Radiotheranostics Market

  • 20.1. Spain Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Radiotheranostics Market

  • 21.1. Eastern Europe Radiotheranostics Market Overview
  • 21.2. Eastern Europe Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Radiotheranostics Market

  • 22.1. Russia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Radiotheranostics Market

  • 23.1. North America Radiotheranostics Market Overview
  • 23.2. North America Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Radiotheranostics Market

  • 24.1. USA Radiotheranostics Market Overview
  • 24.2. USA Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Radiotheranostics Market

  • 25.1. Canada Radiotheranostics Market Overview
  • 25.2. Canada Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Radiotheranostics Market

  • 26.1. South America Radiotheranostics Market Overview
  • 26.2. South America Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Radiotheranostics Market

  • 27.1. Brazil Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Radiotheranostics Market

  • 28.1. Middle East Radiotheranostics Market Overview
  • 28.2. Middle East Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Radiotheranostics Market

  • 29.1. Africa Radiotheranostics Market Overview
  • 29.2. Africa Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Radiotheranostics Market Competitive Landscape And Company Profiles

  • 30.1. Radiotheranostics Market Competitive Landscape
  • 30.2. Radiotheranostics Market Company Profiles
    • 30.2.1. Lantheus Holdings Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Cardinal Health Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. GE Healthcare Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bayer AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novartis AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Radiotheranostics Market Other Major And Innovative Companies

  • 31.1. Siemens Healthineers
  • 31.2. Boston Scientific Corporation
  • 31.3. Terumo Corporation
  • 31.4. Orano Med
  • 31.5. Curium SAS
  • 31.6. IBA Molecular
  • 31.7. The Eckert & Ziegler Group
  • 31.8. Advanced Accelerator Applications (AAA)
  • 31.9. Telix Pharmaceuticals Limited.
  • 31.10. Abdera Therapeutics
  • 31.11. Blue Earth Diagnostics
  • 31.12. Sirtex Medical Limited
  • 31.13. Y-mAbs Therapeutics Inc.
  • 31.14. ITM Radiopharma
  • 31.15. NorthStar Medical Radioisotopes LLC

32. Global Radiotheranostics Market Competitive Benchmarking

33. Global Radiotheranostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Radiotheranostics Market

35. Radiotheranostics Market Future Outlook and Potential Analysis

  • 35.1 Radiotheranostics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Radiotheranostics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Radiotheranostics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer